I think people are misreading what Joe said. There’s no clear cut answer until Generex hears from Nasdaq. And then they’ll learn their path forward. We aren’t the BOD. He can only say what’s publicly known. In my opinion, Joe was just noting Gnbt has a history and has battled back to rise above $2 in the past. This is a quick turnaround for another CC so communication has been great.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links